According to the IMARC Group, the global human growth hormone market to register a CAGR of around 6% during 2020-2025. Human growth hormone, also known as somatotropin or HGH, is a peptide hormone that regulates growth, reproduction, regeneration, repair and metabolism of cells. This hormone is secreted by the pituitary gland to stimulate growth in children and adults. The deficiency of HGH can be treated by administering recombinant HGH by subcutaneous injections.
The rising awareness regarding the efficacy of HGH in the treatment of various conditions represents one of the leading market drivers. For instance, HGH helps in controlling body composition and fluids, sugar and fat metabolism, muscle and bone growth, and recovering from injury among patients suffering from adult GH deficiency. Besides this, the increasing government initiatives to create awareness regarding the GH deficiencies and treatment acts as another significant driver. Moreover, the extensive investment in the research and development (R&D) activities for developing recombinant human growth hormones (rHGH) with fewer side effects and prolonged efficacy is also expected to provide a positive impact on the market in the upcoming years.
Request for free pdf sample copy @ https://www.imarcgroup.com/human-growth-hormone-market/requestsample
Note: As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Breakup by Application:
Growth Hormone (GH) Deficiency
Adult GH Deficiency
Pediatric GH Deficiency
Idiopathic Short Stature (ISS)
Prader-Willi Syndrome (PWS)
Small for Gestational Age
Breakup by Distribution Channel:
Breakup by Route of Administration:
Breakup by Region:
Middle East and Africa
For more information about this report visit: https://www.imarcgroup.com/human-growth-hormone-market
The competitive landscape of the industry has also been examined with some of the key players being Eli Lilly and Company, EMD Serono Inc., F. Hoffmann-La Roche AG, Ferring B.V., Genentech Inc., Ipsen, Merck KGaA, Novartis AG, Novo Nordisk, Pfizer Inc., Sandoz, etc.
Browse more healthcare reports by IMARC Group:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
Contact US: IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Follow us on twitter: @imarcglobal